BIOTECHNOLOGY:Disease Group Invests in Do-It-Yourself Drugs

Area of Science:

• Biomedical Research
• Drug Discovery
• Patient Advocacy

Background:

• Cystic Fibrosis (CF) is a genetic disorder requiring novel therapeutic strategies.
• Patient advocacy groups are increasingly involved in funding and directing research.

Purpose of the Study:

• To identify novel compounds for Cystic Fibrosis treatment.
• To foster collaborations between patient foundations and biotech firms.

Main Methods:

• Investment of $30 million by the Cystic Fibrosis Foundation in Aurora Biosciences.
• Leveraging a $20 million donation from the Bill and Melinda Gates Foundation.

Main Results:

• Initiation of a significant research project focused on CF drug discovery.
• Establishment of a partnership between a major patient foundation and a biotech company.

Conclusions:

• Patient-led funding models can accelerate biomedical research.
• Strategic investments can drive the development of treatments for rare diseases like CF.